Digital healthcare company Ro offers prescriptions for hair loss, menopause, and sexual health.
Now it's becoming the first online pharmacy to offer FDA-approved allergy treatments. The segment includes up to 50 million people in the U.S. who suffer from the chronic condition.
"If you look at a condition like allergies, it's perfect for our platform," Dr. Melynda Barnes, vice president of medical affairs, told Cheddar. "We have the capability of doing everything from diagnosis to delivery of treatment."
Ro is the parent company behind digital health clinics Roman (for men) and Rory (for women) as well as a service for dealing with nicotine addiction called Zero.
Its platforms will offer allergy medicine to patients, which furthers the startup's goal of serving as a one-stop-shop for basic health needs.
"Our goal at Ro is to be a patient's first call, and for us, that means moving toward a primary care practice," Barnes said.
Though many allergy treatments are available over the counter, research shows that 80 percent of people choose the incorrect medication on their own. Using telehealth options for quick access to a certified physician, Ro hopes to take out the guesswork for patients.
"I don't think we'll ever replace in-person care," Barnes said. "In fact, at Ro, our goal is to be a complement to our in-person colleagues."
But that hasn't stopped Ro from expanding into other aspects of personal healthcare, including spreading knowledge to patients online.
The company recently launched Health Guide, a medical handbook that is 30 percent written by doctors and 100 reviewed by them. Ro is promoting the service as a competitor to WebMD.
"Right now, we know that physicians feel like they can spend more time with really sick patients if they can take care of healthier patients through an alternative health care model like telemedicine," Barnes said.
Adam Greenblatt, BetMGM CEO, shares insights on football betting forecasts, the booming sports wagering industry, and the game‑changing enhancements to the app.
The former chief executive of Japanese beverage giant Suntory has acknowledged he was investigated on suspicion of possessing an illegal drug but has asserted his innocence despite resigning from his position.
Kellie Romack, Chief Digital Innovation Officer at ServiceNow, reveals the company’s latest announcement and how it’s shaping the future of work and tech.
Raina Moskowitz, CEO of The Knot Worldwide, unpacks the 2025 Global Wedding Report, from Gen Z trends to how Taylor Swift's wedding could reshape the industry.
Nestlé has dismissed its CEO Laurent Freixe after an investigation into an undisclosed relationship with a direct subordinate. The company announced on Monday that the dismissal was effective immediately. An investigation found that Freixe violated Nestlé’s code of conduct. He had been CEO for a year. Philipp Navratil, a longtime Nestlé executive, will replace him. Chairman Paul Bulcke stated that the decision was necessary to uphold the company’s values and governance. Navratil began his career with Nestlé in 2001 and has held various roles, including CEO of Nestlé's Nespresso division since 2024.
